- Trials with a EudraCT protocol (782)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
782 result(s) found for: Chemotherapy Regimens.
Displaying page 1 of 40.
EudraCT Number: 2006-001150-27 | Sponsor Protocol Number: 2006/01 | Start Date*: 2006-09-11 |
Sponsor Name:University Hospital Gent | ||
Full Title: Sandostatin LAR in prevention of Chemotherapy Induced Diarrhea | ||
Medical condition: Chemo-Therapy Induced Diarrhea | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020660-37 | Sponsor Protocol Number: CR3294-2-01 | Start Date*: 2010-09-08 | ||||||||||||||||
Sponsor Name:ROTTAPHARM S.P.A. | ||||||||||||||||||
Full Title: A Multicenter, randomized, double blind, double dummy, placebo controlled, parallel group, phase II study on the prevention of mucositis by CR3294, orally administered for 5 days in haematological ... | ||||||||||||||||||
Medical condition: assessment of the effect of CR3294 in preventing oral mucositis induced by conditioning myeloablative regimens in patients undergoing high-dose chemotherapy (HDCT) and autologous HSCT. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000686-19 | Sponsor Protocol Number: MO05/6844 | Start Date*: 2005-04-28 |
Sponsor Name:University of Leeds | ||
Full Title: PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy) - A randomised crossover clinical trial comparing Bolus Fluorouracil/Leucovorin to Capecitabine as treatment for moderate to high ri... | ||
Medical condition: Moderate to high risk resected colorectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004473-16 | Sponsor Protocol Number: SL001-2.0 | Start Date*: 2016-07-19 |
Sponsor Name:Masarykův onkologický ústav | ||
Full Title: Prospective study investigating efficacy of lanreotide on decrease of chemotherapy induced diarrhoea (CID) in patiens with colorectal carcinoma. | ||
Medical condition: Chemotherapy induced diarrhoea that is resistant to common treatment including loperamide in patients with colorectal carcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002602-52 | Sponsor Protocol Number: BAY80-6946/16349 | Start Date*: 2012-10-19 | |||||||||||||||||||||
Sponsor Name:Bayer AG | |||||||||||||||||||||||
Full Title: Open-label, uncontrolled Phase II trial of intravenous PI3K inhibitor BAY 80-6946 in patients with relapsed, indolent or aggressive Non-Hodgkin’s lymphomas | |||||||||||||||||||||||
Medical condition: Patients with relapsed, indolent or aggressive Non-Hodgkin’s lymphomas or patients with follicular lymphoma relapsed after or refractory to standard therapy. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) FI (Completed) DE (Completed) BE (Completed) ES (Completed) IT (Completed) SE (Completed) PL (Completed) AT (Completed) PT (Completed) HU (Completed) DK (Prematurely Ended) IE (Completed) GR (Completed) LU (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000515-24 | Sponsor Protocol Number: RG_17-247 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:University of Birmingham | |||||||||||||
Full Title: FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma | |||||||||||||
Medical condition: Rhabdomyosarcoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Ongoing) NO (Ongoing) GB (GB - no longer in EU/EEA) NL (Ongoing) DK (Ongoing) SI (Ongoing) GR (Ongoing) CZ (Ongoing) IT (Ongoing) SE (Ongoing) AT (Ongoing) BE (Ongoing) FI (Ongoing) DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000564-28 | Sponsor Protocol Number: MO18109 | Start Date*: 2004-11-01 |
Sponsor Name:F. Hoffmann-La Roche Ltd | ||
Full Title: An expanded access program of Tarceva (erlotinib) in patients with advanced stage IIIB/ IV non-small cell lung cancer (NSCLC) | ||
Medical condition: advanced stage IIIB/ IV non-small cell lung cancer (NSCLC) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) SK (Completed) SE (Completed) LV (Completed) AT (Completed) HU (Completed) LT (Completed) IE (Completed) CZ (Completed) IT (Prematurely Ended) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002349-50 | Sponsor Protocol Number: M16TGA | Start Date*: 2017-09-29 |
Sponsor Name:Netherlands Cancer Institute- Antoni van Leeuwenhoek Hospital (NKI-AVL) | ||
Full Title: Phase I/II study with galunisertib (LY2157299) combined with capecitabine in patients with advanced chemotherapy resistant colorectal cancer and an activated TGF-β signature | ||
Medical condition: colorectal carcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) BE (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-020147-12 | Sponsor Protocol Number: B1931008 | Start Date*: 2011-02-16 | |||||||||||
Sponsor Name:Pfizer Inc | |||||||||||||
Full Title: AN OPEN-LABEL, RANDOMIZED, PHASE 3 STUDY OF INOTUZUMAB OZOGAMICIN ADMINISTERED IN COMBINATION WITH RITUXIMAB COMPARED TO DEFINED INVESTIGATOR’S CHOICE THERAPY IN SUBJECTS WITH RELAPSED OR REFRACTOR... | |||||||||||||
Medical condition: Aggressive Non-Hodgkin Lymphoma (NHL) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) SE (Completed) ES (Completed) DE (Completed) GB (Completed) HU (Completed) LT (Completed) BG (Completed) BE (Completed) GR (Completed) NL (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001020-20 | Sponsor Protocol Number: NKV101983 | Start Date*: 2005-01-25 |
Sponsor Name:GlaxoSmithKline Group of Companies | ||
Full Title: | ||
Medical condition: Chemotherapy Induced Nausea and Vomiting (CINV) 0 Moderately Emetogenic Chemotherapy (MEC) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) IE (Completed) SK (Completed) HU (Completed) AT (Completed) GB (Completed) DE (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-005068-29 | Sponsor Protocol Number: C2006-01 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:A.P. Pharma, Inc. | |||||||||||||
Full Title: A Pivotal Phase 3 Observer-Blind, Randomized Clinical Trial of the Efficacy and Safety of APF530 Compared to Aloxi® for the Prevention of Acute-Onset and Delayed-Onset Chemotherapy-Induced Nausea a... | |||||||||||||
Medical condition: Chemotherapy Induced Nausea and Vomiting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002417-36 | Sponsor Protocol Number: CAPTEM | Start Date*: 2014-08-28 | ||||||||||||||||
Sponsor Name:Fondazione IRCCS Istituto Nazionale dei Tumori | ||||||||||||||||||
Full Title: An open-label, randomized, multicenter, phase II trial designed to estimate the activity of CAPTEM combination versus FOLFIRI as second line treatment in patients who have progressed on or after fi... | ||||||||||||||||||
Medical condition: colorectal cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-002564-69 | Sponsor Protocol Number: 410/56 | Start Date*: 2014-04-11 | |||||||||||
Sponsor Name:GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH | |||||||||||||
Full Title: Double-blind, placebo-controlled multicenter phase II trial to evaluate the efficacy and safety of romiplostim for the treatment of chemotherapy-induced thrombocytopenia in subjects with relapse... | |||||||||||||
Medical condition: Patients with relapsed ovarian cancer (2nd and 3rd line) treated with chemotherapy according to AGO guidelines who develop thrombocytopenia grade 3 and/or grade 4. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000378-61 | Sponsor Protocol Number: AVF3694g | Start Date*: 2006-05-25 |
Sponsor Name:Genentech | ||
Full Title: ENSAYO CLINICO DE FASE III MULTICÉNTRICO, RANDOMIZADO, CONTROLADO CON PLACEBO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE BEVACIZUMAB EN COMBINACIÓN CON DIVERSOS REGÍMENES DE QUIMIOTERAPIA EN PACIENTE... | ||
Medical condition: Cáncer de mama metastásico Metastatic breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) GB (Completed) NL (Completed) SE (Completed) GR (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005294-30 | Sponsor Protocol Number: WSA-CS-002 | Start Date*: 2006-05-10 |
Sponsor Name:Basilea Pharmaceutica Ltd. | ||
Full Title: Open-label, multi-center, sequential group, clinical study to determine the safety and efficacy of escalating dosing regimens of intravenous or oral BAL8557 in the prophylaxis of patients undergoin... | ||
Medical condition: Neutropenic patients over 18 years with acute myeloid leukemia (AML). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000266-11 | Sponsor Protocol Number: 2012-772 | Start Date*: 2014-05-27 |
Sponsor Name:HOSPICES CIVILS DE LYON | ||
Full Title: Multicenter, randomized trial of carboplatin +/- paclitaxel in vulnerable elderly patients with stage III-IV advanced ovarian cancer. | ||
Medical condition: Vulnerable elderly women with newly diagnosed stage III-IV ovarian cancer after an initial debulking surgery or with a planned interval debulking surgery. | ||
Disease: | ||
Population Age: Elderly | Gender: Female | |
Trial protocol: IT (Completed) IE (Completed) DK (Prematurely Ended) FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005688-18 | Sponsor Protocol Number: Paw1 | Start Date*: 2016-05-25 | |||||||||||
Sponsor Name:Department of Hematology, Aalborg University Hospital | |||||||||||||
Full Title: A randomized controlled trial of alendronate as preventive treatment against the development of gluco-corticoid-induced osteoporosis in patients being treated for malignant lymphoma | |||||||||||||
Medical condition: Age ≥ 18 years. Patients with new diagnosis or recurrence of lymphoma, which is expected to be treated with one of the listed chemotherapy regimens. Expected lifespan ≥2 years | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000259-99 | Sponsor Protocol Number: RG_13-277 | Start Date*: 2014-08-29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:University of Birmingham | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: International randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Recurrent and refractory Ewing sarcoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) FI (Ongoing) DE (Ongoing) HU (Ongoing) CZ (Ongoing) BE (Ongoing) NL (Ongoing) PL (Completed) IT (Temporarily Halted) AT (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004447-23 | Sponsor Protocol Number: Parity | Start Date*: 2014-03-25 | |||||||||||
Sponsor Name:Tays [...] | |||||||||||||
Full Title: Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center Randomized Controlled Study Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections with Endopro... | |||||||||||||
Medical condition: Postoperative infection prevention | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: | ||||||||||||
Trial protocol: FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003669-36 | Sponsor Protocol Number: MS100070_0119 | Start Date*: 2022-09-13 | |||||||||||
Sponsor Name:Merck Healthcare KGaA | |||||||||||||
Full Title: A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination with Other Anti-Tumor Agents as a Maintenance Treatment in Participants with L... | |||||||||||||
Medical condition: Advanced or metastatic urothelial carcinoma whose disease did not progress with 1L platinum-containing chemotherapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) ES (Ongoing) FR (Ongoing) DK (Completed) GR (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.